The Leaders’ Summit, co-sponsored by The Wall Street Journal, is one of the most prestigious,
annual R&D meetings in North America. Each year over one-hundred senior managers gather to
discuss and debate the most pressing R&D issues facing the biopharmaceutical industry and their organizations.

Hear Pharmaceutical and Biotech Leaders Present on the Following Topics: Translational Medicine’s Impact or Non-Impact on R&D Productivity in the Near Term The Globalization of Drug Development with Emphasis on China and India How Can Changes in the R&D Business Model Enable Better Risk Management How Should We Approach Our Portfolio Strategy Moving into the Future? Re-Engineering Drug Safety Risk Management Models Networking Features Include: Executive Roundtable Discussions Executive Dinner Roundtables Three Concurrent, Interactive Breakout Sessions Two Concurrent Biotech and Pharmaceutical Breakout Sessions